These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16457645)

  • 41. Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
    Kroeger KM; Muhammad AK; Baker GJ; Assi H; Wibowo MK; Xiong W; Yagiz K; Candolfi M; Lowenstein PR; Castro MG
    Discov Med; 2010 Oct; 10(53):293-304. PubMed ID: 21034670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in immunotherapeutic research for glioma therapy.
    Miyauchi JT; Tsirka SE
    J Neurol; 2018 Apr; 265(4):741-756. PubMed ID: 29209782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Active immunotherapy: oncolytic virus therapy using HSV-1.
    Todo T
    Adv Exp Med Biol; 2012; 746():178-86. PubMed ID: 22639168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oncolytic measles virus strains in the treatment of gliomas.
    Allen C; Paraskevakou G; Liu C; Iankov ID; Msaouel P; Zollman P; Myers R; Peng KW; Russell SJ; Galanis E
    Expert Opin Biol Ther; 2008 Feb; 8(2):213-20. PubMed ID: 18194077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunotherapy targeting glioma stem cells--insights and perspectives.
    Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
    Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune and viral therapies for malignant primary brain tumors.
    Gardeck AM; Sheehan J; Low WC
    Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical trials of viral therapy for malignant gliomas.
    Piccioni DE; Kesari S
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1297-305. PubMed ID: 24138481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in gene therapy and immunotherapy for brain tumors.
    Kew Y; Levin VA
    Curr Opin Neurol; 2003 Dec; 16(6):665-70. PubMed ID: 14624074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
    Samson A; Scott KJ; Taggart D; West EJ; Wilson E; Nuovo GJ; Thomson S; Corns R; Mathew RK; Fuller MJ; Kottke TJ; Thompson JM; Ilett EJ; Cockle JV; van Hille P; Sivakumar G; Polson ES; Turnbull SJ; Appleton ES; Migneco G; Rose AS; Coffey MC; Beirne DA; Collinson FJ; Ralph C; Alan Anthoney D; Twelves CJ; Furness AJ; Quezada SA; Wurdak H; Errington-Mais F; Pandha H; Harrington KJ; Selby PJ; Vile RG; Griffin SD; Stead LF; Short SC; Melcher AA
    Sci Transl Med; 2018 Jan; 10(422):. PubMed ID: 29298869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oncolytic viruses for therapy of malignant glioma].
    Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
    Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Oncolytic viruses in the therapy of gliomas].
    Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concepts of immunotherapy for glioma.
    Patel MA; Pardoll DM
    J Neurooncol; 2015 Jul; 123(3):323-30. PubMed ID: 26070552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene therapy strategies for intracranial tumours: glioma and pituitary adenomas.
    Castro MG; Cowen R; Smith-Arica J; Williams J; Ali S; Windeatt S; Gonzalez-Nicolini V; Maleniak T; Lowenstein PR
    Histol Histopathol; 2000 Oct; 15(4):1233-52. PubMed ID: 11005248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy.
    Loya J; Zhang C; Cox E; Achrol AS; Kesari S
    CNS Oncol; 2019 Nov; 8(3):CNS40. PubMed ID: 31747784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research.
    Lou E
    Ann Med; 2004; 36(1):2-8. PubMed ID: 15000342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
    Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peptide vaccine.
    Izumoto S
    Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene therapeutics: the future of brain tumor therapy?
    Cutter JL; Kurozumi K; Chiocca EA; Kaur B
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
    Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
    Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.